Author Affiliations: DermSurgery Associates, Houston, Texas (Drs Moody, Kazakevich, Smith, Holzer, and Goldberg and Ms Landau); Department of Dermatology, Weill Cornell Medical College, Methodist Hospital, Houston (Drs Kazakevich, Smith, Holzer, and Goldberg); St Joseph Dermatology, Houston (Dr Tschen); and Department of Dermatology, University of Texas, Houston (Dr Goldberg).
Graft vs host disease (GVHD) is an immunologically mediated disorder. Donor lymphocytes (T cells) from transplanted tissues attack major histocompatibility complex (MHC) antigens on cells of the immunosuppressed recipient.1 Classic targets are rapidly dividing cells of the liver, gastrointestinal tract, skin and bone marrow, giving rise to clinical manifestations of jaundice, diarrhea, dermatitis, and pancytopenia.
Moody MN, Kazakevich N, Smith JR, et al. Sweat the Small Stuff: The Importance of Clinical-Pathologic Correlation in Cutaneous GVHD Following Orthotopic Liver Transplant. Arch Dermatol. 2011;147(11):1345–1346. doi:10.1001/archdermatol.2011.331
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: